Among patients with rheumatoid arthritis, JAK inhibitors were slightly more effective for reducing pain at 3 and 12 months when compared with TNF inhibitors.

A recent meta-analysis published in JAMA Neurology has revealed that tumor necrosis factor (TNF) inhibitors, widely used in treating autoimmune diseases, may increase the risk of ...

Tumour Necrosis Factor TNF is crucial for defence but can drive chronic inflammation linked to arthritis and autoimmune diseases when overproduced ...

The use of IL-17 inhibitors in patients with psoriasis was associated with an increased risk for fungal infections when compared with other biologics.

Whereas 89.5% of new prescriptions for disease-modifying anti-rheumatic drugs (DMARDs) in 2000 were for old-line agents, by ...

Filgotinib, the rheumatoid arthritis (RA) oral drug that never made it to the U.S. market but is sold across Europe, Great ...

Tumor necrosis factor (TNF) inhibitors are associated with a reduced risk for recurrent cardiovascular events in patients with radiographic axial spondyloarthritis (axSpA) and a history of ...

The lesion-specific 12-month cumulative incidence of radiographic radiation necrosis was 3.5% in the combination arm vs 3.2% in the immune checkpoint inhibitor–first arm. Although combining the two ...

Q3 highlights: * Patients without previous exposure to biologics ** Patients with an inadequate response to TNF inhibitors Third quarter 2024 financial results As of September 30, 2024, MoonLake held ...

Tyr Pharma has a pivotal year ahead with key readouts for Efzofitimod, potentially opening a huge market. Find out why ATYR ...

Big news out of New Jersey this morning as a %Biotech company said it received “positive feedback” from the European ...